top of page

Making Breakthrough Discoveries

with Stealth-Body Technology

Smart Cell Targeting

Stealth-Body

항체의 구조
  • Proprietary mutations for reduced Fc-effector functions.

  • CrossPoint’s Stealth-Body shows no binding or activity above background across Fc gamma receptors, far surpassing all previously described modifications.

  • CrossPoint’s Stealth-Body limits off-target toxicity issues for the development of next-generation antibody therapies.

연구-이미지3_edited.jpg

MISSION

Key to the success of

novel drug development

CrossPoint Therapeutics strives to develop drugs that

expands the range of curable disease as well as

providing dignity and better life to patients.

Investor & Media

OUR NEWS

IN PRESS MEDIA

Check out the latest news

about our company below.

bottom of page